125 related articles for article (PubMed ID: 29016387)
21. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
22. The absolute lymphocyte to monocyte ratio is associated with poor prognosis in classical Hodgkin lymphoma patients younger than 60 years of age.
Koh YW; Jung SJ; Yoon DH; Suh C; Cha HJ; Go H; Kim JE; Kim CW; Huh J
Hematol Oncol; 2015 Sep; 33(3):133-40. PubMed ID: 25224646
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
[TBL] [Abstract][Full Text] [Related]
24. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy.
Grignol VP; Smith AD; Shlapak D; Zhang X; Del Campo SM; Carson WE
Surg Oncol; 2015 Dec; 24(4):353-8. PubMed ID: 26690825
[TBL] [Abstract][Full Text] [Related]
25. A Retrospective Analysis of the Efficacy of Pembrolizumab in Melanoma Patients With Brain Metastasis.
Dagogo-Jack I; Lanfranchi M; Gainor JF; Giobbie-Hurder A; Lawrence DP; Shaw AT; Sullivan RJ
J Immunother; 2017 Apr; 40(3):108-113. PubMed ID: 28221189
[TBL] [Abstract][Full Text] [Related]
26. Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple Myeloma.
Tian Y; Zhang Y; Zhu WQ; Chen XL; Zhou HB; Chen WM
Biomed Res Int; 2018; 2018():9434637. PubMed ID: 30599001
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy.
Lin GN; Liu PP; Liu DY; Peng JW; Xiao JJ; Xia ZJ
Chin J Cancer; 2016 Jan; 35():5. PubMed ID: 26740116
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma.
Iacono D; Basile D; Gerratana L; Vitale MG; Pelizzari G; Cinausero M; Poletto E; Puglisi F; Fasola G; Minisini AM
Melanoma Res; 2019 Oct; 29(5):510-515. PubMed ID: 30702508
[TBL] [Abstract][Full Text] [Related]
29. Infused autograft lymphocyte to monocyte ratio and survival in diffuse large B cell lymphoma.
Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Hogan WJ; Markovic SN
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1804-12. PubMed ID: 25042737
[TBL] [Abstract][Full Text] [Related]
30. Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab.
Weide B; Martens A; Hassel JC; Berking C; Postow MA; Bisschop K; Simeone E; Mangana J; Schilling B; Di Giacomo AM; Brenner N; Kähler K; Heinzerling L; Gutzmer R; Bender A; Gebhardt C; Romano E; Meier F; Martus P; Maio M; Blank C; Schadendorf D; Dummer R; Ascierto PA; Hospers G; Garbe C; Wolchok JD
Clin Cancer Res; 2016 Nov; 22(22):5487-5496. PubMed ID: 27185375
[TBL] [Abstract][Full Text] [Related]
31. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
Hutterer GC; Sobolev N; Ehrlich GC; Gutschi T; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R; Pichler M; Dalpiaz O
J Clin Pathol; 2015 May; 68(5):351-5. PubMed ID: 25661796
[TBL] [Abstract][Full Text] [Related]
32. Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
Ribas A; Hamid O; Daud A; Hodi FS; Wolchok JD; Kefford R; Joshua AM; Patnaik A; Hwu WJ; Weber JS; Gangadhar TC; Hersey P; Dronca R; Joseph RW; Zarour H; Chmielowski B; Lawrence DP; Algazi A; Rizvi NA; Hoffner B; Mateus C; Gergich K; Lindia JA; Giannotti M; Li XN; Ebbinghaus S; Kang SP; Robert C
JAMA; 2016 Apr; 315(15):1600-9. PubMed ID: 27092830
[TBL] [Abstract][Full Text] [Related]
33. Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Chen YM; Lai CH; Chang HC; Chao TY; Tseng CC; Fang WF; Wang CC; Chung YH; Wang YH; Su MC; Huang KT; Chen HC; Chang YC; Lin MC
PLoS One; 2015; 10(8):e0136252. PubMed ID: 26313661
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of blood cell count-derived ratios in BRAF-mutated metastatic melanoma.
Kopecky J; Kubecek O; Priester P; Vosmikova H; Cermakova E; Kyllarova A
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Dec; 166(4):393-404. PubMed ID: 34446937
[TBL] [Abstract][Full Text] [Related]
35. Pembrolizumab versus Ipilimumab in Advanced Melanoma.
Robert C; Schachter J; Long GV; Arance A; Grob JJ; Mortier L; Daud A; Carlino MS; McNeil C; Lotem M; Larkin J; Lorigan P; Neyns B; Blank CU; Hamid O; Mateus C; Shapira-Frommer R; Kosh M; Zhou H; Ibrahim N; Ebbinghaus S; Ribas A;
N Engl J Med; 2015 Jun; 372(26):2521-32. PubMed ID: 25891173
[TBL] [Abstract][Full Text] [Related]
36. Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients.
Ferrucci PF; Gandini S; Battaglia A; Alfieri S; Di Giacomo AM; Giannarelli D; Cappellini GC; De Galitiis F; Marchetti P; Amato G; Lazzeri A; Pala L; Cocorocchio E; Martinoli C
Br J Cancer; 2015 Jun; 112(12):1904-10. PubMed ID: 26010413
[TBL] [Abstract][Full Text] [Related]
37. Peripheral blood lymphocyte to monocyte ratio recovery from low levels at diagnosis after completion of first line therapy predicts good clinical outcomes in patients with diffuse large B-cell lymphoma.
Zhou S; Xu L; Ma Y; Tang L; Zhang Y; Shi Y; Sun L; Chen Y; Liang B; Zhou Y; Yu K; Shen J
Oncotarget; 2017 Mar; 8(12):19556-19565. PubMed ID: 28107187
[TBL] [Abstract][Full Text] [Related]
38. Effect of the lymphocyte-to-monocyte ratio on the clinical outcome of chemotherapy administration in advanced melanoma patients.
Leontovich AA; Dronca RS; Nevala WK; Thompson MA; Kottschade LA; Ivanov LV; Markovic SN;
Melanoma Res; 2017 Feb; 27(1):32-42. PubMed ID: 27824739
[TBL] [Abstract][Full Text] [Related]
39. Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort Study of 2 Countries.
Xue P; Hang J; Huang W; Li S; Li N; Kodama Y; Matsumoto S; Takaori K; Zhu L; Kanai M
Pancreas; 2017 Sep; 46(8):1011-1017. PubMed ID: 28787331
[TBL] [Abstract][Full Text] [Related]
40. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
